Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1997 Sep;41(9):1979–1984. doi: 10.1128/aac.41.9.1979

Amoxicillin treatment of experimental acute otitis media caused by Haemophilus influenzae with non-beta-lactamase-mediated resistance to beta-lactams: aspects of virulence and treatment.

A Melhus 1, H Janson 1, E Westman 1, A Hermansson 1, A Forsgren 1, K Prellner 1
PMCID: PMC164048  PMID: 9303397

Abstract

Through alterations primarily in the penicillin-binding proteins, a non-beta-lactamase-mediated resistance to beta-lactams has evolved in Haemophilus influenzae. The virulence of these chromosomally changed strains has been questioned. To ascertain whether these alterations involve a reduction in virulence of H. influenzae and whether they could be advantageous for the bacterium during amoxicillin treatment of acute otitis media, a total of 70 Sprague-Dawley rats were challenged with a susceptible recipient strain or a genetically similar resistant transformant strain. Antibiotic therapy was started on day 3 after inoculation, and the animals were monitored by daily otomicroscopy and analysis of bacterial samples from middle ear effusions obtained on day 8, the last day of observation. The animals were also sacrificed on days 4 and 8 and after 2 months for morphological examination. Compared with the susceptible recipient strain, recovery from infections caused by the resistant transformant strain was delayed, and the late structural changes were more severe in the animals challenged with the latter strain. The results of the study indicate that chromosomal alterations mediating a relatively low level of resistance to beta-lactams may be advantageous for H. influenzae during antibiotic treatment of a local infection in the rat, and the alterations may occur without any significant loss of virulence.

Full Text

The Full Text of this article is available as a PDF (578.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BARNHART B. J., HERRIOTT R. M. PENETRATION OF DEOXYRIBONUCLEIC ACID INTO HEMOPHILUS INFLUENZAE. Biochim Biophys Acta. 1963 Sep 17;76:25–39. [PubMed] [Google Scholar]
  2. Clairoux N., Picard M., Brochu A., Rousseau N., Gourde P., Beauchamp D., Parr T. R., Jr, Bergeron M. G., Malouin F. Molecular basis of the non-beta-lactamase-mediated resistance to beta-lactam antibiotics in strains of Haemophilus influenzae isolated in Canada. Antimicrob Agents Chemother. 1992 Jul;36(7):1504–1513. doi: 10.1128/aac.36.7.1504. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Dargis M., Gourde P., Beauchamp D., Foiry B., Jacques M., Malouin F. Modification in penicillin-binding proteins during in vivo development of genetic competence of Haemophilus influenzae is associated with a rapid change in the physiological state of cells. Infect Immun. 1992 Oct;60(10):4024–4031. doi: 10.1128/iai.60.10.4024-4031.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Doern G. V., Jorgensen J. H., Thornsberry C., Preston D. A., Tubert T., Redding J. S., Maher L. A. National collaborative study of the prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae. Antimicrob Agents Chemother. 1988 Feb;32(2):180–185. doi: 10.1128/aac.32.2.180. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Fomsgaard A., Shand G. H., Freudenberg M. A., Galanos C., Conrad R. S., Kronborg G., Høiby N. Antibodies from chronically infected cystic fibrosis patients react with lipopolysaccharides extracted by new micromethods from all serotypes of Pseudomonas aeruginosa. APMIS. 1993 Feb;101(2):101–112. doi: 10.1111/j.1699-0463.1993.tb00088.x. [DOI] [PubMed] [Google Scholar]
  6. GOODGAL S. H., HERRIOTT R. M. Studies on transformations of Hemophilus influenzae. I. Competence. J Gen Physiol. 1961 Jul;44:1201–1227. doi: 10.1085/jgp.44.6.1201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gutmann L., Williamson R., Collatz E., Acar J. F. Mechanisms of beta-lactam resistance in Haemophilus influenzae. Eur J Clin Microbiol Infect Dis. 1988 Oct;7(5):610–615. doi: 10.1007/BF01964237. [DOI] [PubMed] [Google Scholar]
  8. Hermansson A., Hellstrom S., Prellner K. Mucosal changes induced by experimental pneumococcal otitis media are prevented by penicillin V. Otolaryngol Head Neck Surg. 1991 Oct;105(4):578–585. doi: 10.1177/019459989110500409. [DOI] [PubMed] [Google Scholar]
  9. Howie V. M., Dillard R., Lawrence B. In vivo sensitivity test in otitis media: efficacy of antibiotics. Pediatrics. 1985 Jan;75(1):8–13. [PubMed] [Google Scholar]
  10. Jacobs R. F., Wells T. G., Steele R. W., Yamauchi T. A prospective randomized comparison of cefotaxime vs ampicillin and chloramphenicol for bacterial meningitis in children. J Pediatr. 1985 Jul;107(1):129–133. doi: 10.1016/s0022-3476(85)80634-x. [DOI] [PubMed] [Google Scholar]
  11. Janson H., Melhus A., Hermansson A., Forsgren A. Protein D, the glycerophosphodiester phosphodiesterase from Haemophilus influenzae with affinity for human immunoglobulin D, influences virulence in a rat otitis model. Infect Immun. 1994 Nov;62(11):4848–4854. doi: 10.1128/iai.62.11.4848-4854.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kayser F. H., Morenzoni G., Santanam P. The Second European Collaborative Study on the frequency of antimicrobial resistance in Haemophilus influenzae. Eur J Clin Microbiol Infect Dis. 1990 Nov;9(11):810–817. doi: 10.1007/BF01967379. [DOI] [PubMed] [Google Scholar]
  13. Kilian M. A taxonomic study of the genus Haemophilus, with the proposal of a new species. J Gen Microbiol. 1976 Mar;93(1):9–62. doi: 10.1099/00221287-93-1-9. [DOI] [PubMed] [Google Scholar]
  14. Levy J. Antibiotic resistance in Europe and the current use of antibiotics in severe pediatric infections. Scand J Infect Dis Suppl. 1990;73:23–29. [PubMed] [Google Scholar]
  15. Magnuson K., Hermansson A., Melhus A., Hellström S. The tympanic membrane and middle ear mucosa during non-typeable Haemophilus influenzae and Haemophilus influenzae type b acute otitis media: a study in the rat. Acta Otolaryngol. 1997 May;117(3):396–405. doi: 10.3109/00016489709113412. [DOI] [PubMed] [Google Scholar]
  16. Markowitz S. M. Isolation of an ampicillin-resistant, non-beta-lactamase-producing strain of Haemophilus influenzae. Antimicrob Agents Chemother. 1980 Jan;17(1):80–83. doi: 10.1128/aac.17.1.80. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Mathies A. W., Jr Penicillins in the treatment of bacterial meningitis. J R Coll Physicians Lond. 1972 Jan;6(2):139–146. [PMC free article] [PubMed] [Google Scholar]
  18. Melhus A., Hermansson A., Prellner K. Nontypeable and encapsulated Haemophilus influenzae yield different clinical courses of experimental otitis media. Acta Otolaryngol. 1994 May;114(3):289–294. doi: 10.3109/00016489409126058. [DOI] [PubMed] [Google Scholar]
  19. Mendelman P. M., Chaffin D. O., Krilov L. R., Kalaitzoglou G., Serfass D. A., Onay O., Wiley E. A., Overturf G. D., Rubin L. G. Cefuroxime treatment failure of nontypable Haemophilus influenzae meningitis associated with alteration of penicillin-binding proteins. J Infect Dis. 1990 Nov;162(5):1118–1123. doi: 10.1093/infdis/162.5.1118. [DOI] [PubMed] [Google Scholar]
  20. Mendelman P. M. Targets of the beta-lactam antibiotics, penicillin-binding proteins, in ampicillin-resistant, non-beta-lactamase-producing Haemophilus influenzae. J Infect Dis. 1992 Jun;165 (Suppl 1):S107–S109. doi: 10.1093/infdis/165-supplement_1-s107. [DOI] [PubMed] [Google Scholar]
  21. Mendelman P. M., Wiley E. A., Stull T. L., Clausen C., Chaffin D. O., Onay O. Problems with current recommendations for susceptibility testing of Haemophilus influenzae. Antimicrob Agents Chemother. 1990 Aug;34(8):1480–1484. doi: 10.1128/aac.34.8.1480. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Moxon E. R., Deich R. A., Connelly C. Cloning of chromosomal DNA from Haemophilus influenzae. Its use for studying the expression of type b capsule and virulence. J Clin Invest. 1984 Feb;73(2):298–306. doi: 10.1172/JCI111214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Mygind N., Meistrup-Larsen K. I., Thomsen J., Thomsen V. F., Josefsson K., Sørensen H. Penicillin in acute otitis media: a double-blind placebo-controlled trial. Clin Otolaryngol Allied Sci. 1981 Feb;6(1):5–13. doi: 10.1111/j.1365-2273.1981.tb01781.x. [DOI] [PubMed] [Google Scholar]
  24. Offit P. A., Campos J. M., Plotkin S. A. Ampicillin-resistant, beta-lactamase-negative haemophilus influenzae type b. Pediatrics. 1982 Feb;69(2):230–232. [PubMed] [Google Scholar]
  25. Poulsen K., Hjorth J. P., Kilian M. Limited diversity of the immunoglobulin A1 protease gene (iga) among Haemophilus influenzae serotype b strains. Infect Immun. 1988 Apr;56(4):987–992. doi: 10.1128/iai.56.4.987-992.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Powell M., Yeo S. F., Seymour A., Yuan M., Williams J. D., Fah Y. S. Antimicrobial resistance in Haemophilus influenzae from England and Scotland in 1991. J Antimicrob Chemother. 1992 May;29(5):547–554. doi: 10.1093/jac/29.5.547. [DOI] [PubMed] [Google Scholar]
  27. Rousseau N., Dargis M., Gourde P., Beauchamp D., Malouin F. Effect of beta-lactams on peptidoglycan metabolism of Haemophilus influenzae grown in animals. Antimicrob Agents Chemother. 1992 Oct;36(10):2147–2155. doi: 10.1128/aac.36.10.2147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Rubin L. G., Mendelman P. M., Rakita R. M., Rosen H. Virulence of non-beta-lactamase-mediated ampicillin-resistant Haemophilus influenzae. FEMS Microbiol Lett. 1991 Nov 1;68(1):27–31. doi: 10.1016/0378-1097(91)90389-r. [DOI] [PubMed] [Google Scholar]
  29. Schägger H., von Jagow G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem. 1987 Nov 1;166(2):368–379. doi: 10.1016/0003-2697(87)90587-2. [DOI] [PubMed] [Google Scholar]
  30. Torres-Molina F., Peris-Ribera J. E., García-Carbonell M. C., Aristorena J. C., Granero L., Plá-Delfina J. M. Nonlinearities in amoxycillin pharmacokinetics. I. Disposition studies in the rat. Biopharm Drug Dispos. 1992 Jan;13(1):23–38. doi: 10.1002/bdd.2510130103. [DOI] [PubMed] [Google Scholar]
  31. Torres-Molina F., Peris-Ribera J. E., García-Carbonell M. C., Aristorena J. C., Plá-Delfina J. M. Nonlinearities in amoxycillin pharmacokinetics. II. Absorption studies in the rat. Biopharm Drug Dispos. 1992 Jan;13(1):39–53. doi: 10.1002/bdd.2510130104. [DOI] [PubMed] [Google Scholar]
  32. Vogel L., van Alphen L., Geluk F., Troelstra A., Martin E., Bredius R., Eijk P., Jansen H., Dankert J. Quantitative flow cytometric analysis of opsonophagocytosis and killing of nonencapsulated Haemophilus influenzae by human polymorphonuclear leukocytes. Clin Diagn Lab Immunol. 1994 Jul;1(4):394–400. doi: 10.1128/cdli.1.4.394-400.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. van Buchem F. L., Peeters M. F., van 't Hof M. A. Acute otitis media: a new treatment strategy. Br Med J (Clin Res Ed) 1985 Apr 6;290(6474):1033–1037. doi: 10.1136/bmj.290.6474.1033. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES